BeiGene Announces Clinical Data on BRUKINSA™ (Zanubrutinib) at the 61st American Society of Hematology (ASH) Annual Meeting

    NEXT STORY
    Vaccine fra Janssen og Bavarian Nordic introduceres i Rwanda til at styrke beredskabet mod ebola
    PREV STORY
    Kura Oncology Reports Clinical and Regulatory Updates for Tipifarnib in Angioimmunoblastic T-Cell Lymphoma
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BioMarin Receives Orphan Drug Designation From FDA for First AAV-Factor VIII Gene Therapy, BMN 270, for Patients With Hemophilia A

    SAN RAFAEL, Calif., March 01, 2016 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced ...

    author_avatar
    NASDAQ Market News

    IV Infusion Pump Accessories Market is poised to register a CAGR of 4.5% by 2025 – Persistence Market Research

    The global IV infusion pump accessories market is expected to grow at a steady ...

    author_avatar
    NASDAQ Market News

    Interpace Diagnostics Enters Agreement with One of the Largest, Integrated Health Systems in the US

    author_avatar
    NASDAQ Market News